Oct 26, 2016
By Deepa Rangachari
This podcast focuses on the use of trastuzumab in adjuvant therapy for early stage, Her2-positive breast cancer and ongoing efforts to identify predictive and prognostic biomarkers for the assessment of treatment-related cardiac toxicity.
Related Article: Role of Troponins I and T and N-Terminal...
Oct 3, 2016
If you are an oncologist and think that it isn’t part of your job to listen to your patients talk about depression, I urge you to re-consider. As Sullivan and colleagues show, depression can be lethal.